You’re reading the web edition of STAT’s AI Prognosis newsletter, our subscriber-exclusive guide to artificial intelligence in health care and medicine. Sign up to get it delivered in your inbox every Wednesday.  Remember how I mentioned the “inexplicable kites” on Epic’s campus last week? Well, reader Michael K. Sherman, who is the guy who flies the kites […]

Health Tech Correspondent Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics. His stories explore how tech is changing the practice of health care and the business and policy challenges to realizing tech’s promise. He’s also the co-author of the free, twice weekly STAT Health Tech […]

AbbVie on Monday said it will buy Gilgamesh Pharmaceuticals’ investigational psychedelic drug to treat major depression, a sign that pharma companies are warming up more to the burgeoning field. The pharma giant will acquire the treatment, called bretisilocin, for up to $1.2 billion, including an upfront payment and development milestones. Meanwhile, Gilgamesh will spin off […]

WASHINGTON — The Food and Drug Administration announced Friday that it has begun publishing reports of adverse events concerning drugs and biological products on a daily basis. Previously, the database of the reports, called the FDA Adverse Event Reporting System, was updated quarterly.  “People who navigate the government’s clunky adverse event reporting websites should not […]

NEW YORK — The U.S. Department of Health and Human Services has moved to strip thousands of federal health agency employees of their collective bargaining rights, according to a union that called the effort illegal. HHS officials confirmed Friday that the department is ending its recognition of unions for a number of employees, and are […]

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. The Supreme Court is allowing the Trump administration to cut $783 million in research grants tied to DEI work. Also, STAT just unveiled its special report on the 2025 rankings of the […]

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we see fallout from the FDA’s rejection of Replimune’s melanoma drug affecting another biotech, learn how Sarepta’s decision-making has affected a patient population that hasn’t always been in the headlines, and more. As Sarepta […]

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. The theme of today’s newsletter seems to be: $$$ money $$$ Specifically: What’s driving health costs up? What’s getting covered by insurance and what isn’t? Who’s doing anything about it? But also, mosquitos. How AI scribes […]